skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Found 674 results for your search:
Relevant funding data is only available when one cancer type or one research topic is selected.
Fiscal Year FY 2012
Cancer Type [Hodgkins disease, Non Hodgkins Lymphoma]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 674 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount Principal
Investigator
Institution
1
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA 5R01CA101700-08 $358,748 GLICKSON, JERRY UNIVERSITY OF PENNSYLVANIA
2
A bifunctional nanomedicine for both specific imaging and targeting therapy of an 5R01CA151955-03 $309,964 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE
3
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $354,811 Rothman, Nat DCEG (NCI)
4
A Fourth Outcome: DNA Damage and the Differentiation of B Cells 5R01CA156674-02 $314,884 TEITELL, MICHAEL UNIVERSITY OF CALIFORNIA AT LOS ANGELES
5
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera 5R01CA139119-03 $260,852 Chaudhary, Preet UNIVERSITY OF SOUTHERN CALIFORNIA
6
A Highly Multiplexed PCR Platform for Gene Expression Profiling from FFPE Tissue 1R33CA160011-01A1 $335,186 Nolling, Jork PRIMERADX, INC.
7
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1 ZIABC011064 $151,742 Mock, Beverly CCR (NCI)
8
A multi-center international hospital-based case-control study of lymphoma in Asia (AsiaLymph) ZIA CP010136-10512 $1,810,434 Lan, Qing DCEG (NCI)
9
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE 5U54CA155496-02 $1,712,824 COLDITZ, GRAHAM WASHINGTON UNIVERSITY
10
A novel enzymatic activity of WSTF and its role in tumorigenesis 5R00CA131560-05 $241,530 Xiao, zhuo YALE UNIVERSITY
11
A Phase I trial combining fenretinide and safingol to target overproduction of di 5R21CA161889-02 $311,717 REYNOLDS, CHARLES TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
12
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma 5R01CA149445-02 $549,324 BIRMANN, BRENDA BRIGHAM AND WOMEN'S HOSPITAL
13
A Role for KSHV in the Pathogenesis of Malignancies ZIASC010356 $343,957 Tosato, Giovanna CCR (NCI)
14
Abramson Cancer Center Support Grant 5P30CA016520-36 $7,725,062 DANG, CHI UNIVERSITY OF PENNSYLVANIA
15
Academic Training in Medical Oncology 3T32CA009297-29S1 $68,072 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA AT LOS ANGELES
16
Academic Training in Medical Oncology 5T32CA009297-29 $322,328 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA AT LOS ANGELES
17
Activation of BCL-2 in Hematologic Malignancies 5R01CA056764-18 $281,785 BOXER, LINDA PALO ALTO INSTITUTE FOR RES & EDU, INC.
18
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS 5R01CA136470-04 $318,518 SLECKMAN, BARRY WASHINGTON UNIVERSITY
19
Activation of Proto-Oncogenes by Chromosomal Translocation ZIASC010378 $441,016 Aplan, Peter CCR (NCI)
20
Adult Leukemia Research Center 2P01CA018029-37A1 $4,225,448 APPELBAUM, FREDERICK FRED HUTCHINSON CANCER RESEARCH CENTER
21
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center 5U01CA096230-10 $832,033 MCGRATH, MICHAEL UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
22
AIDS Malignancy Clinical Trials Consortium (AMC) 3U01CA121947-05S1 $450,000 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA AT LOS ANGELES
23
AIDS Malignancy Clinical Trials Consortium (AMC) 5U01CA121947-06 $6,010,333 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA AT LOS ANGELES
24
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIABC011415 $30,333 Kochenderfer, James CCR (NCI)
25
Allotransplant for DOCK8 deficiency ZIABC011374 $163,456 Hickstein, Dennis CCR (NCI)
26
Altered cellular bioenergetics influences NKT cell mediated responses to Lymphoma 5R21CA162277-02 $163,125 Webb, Tonya UNIVERSITY OF MARYLAND BALTIMORE
27
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression 5R01CA130752-05 $299,900 FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA
28
Analysis of the p53 in vivo using a unique mouse model 5R01CA100193-10 $330,583 EVAN, GERARD UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
29
Anatomic Pathology Residency Program ZIEBC011384 $1,082,541 Oberholtzer, John CCR (NCI)
30
Animal Model and Genotyping Core Support Facility ZICBC011047 $1,205,211 DuBois, Wendy CCR (NCI)
31
Annual International Primary CNS Lymphoma Collaborative Group Meeting 2R13CA124293-06A1 $7,500 Batchelor, Tracy MASSACHUSETTS GENERAL HOSPITAL
32
Anti-viral DC/NK interactions 5R01CA108609-09 $176,961 MUNZ, CHRISTIAN UNIVERSITY OF ZURICH
33
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies ZIABC010647 $297,122 Rader, Christoph CCR (NCI)
34
Antibody-CpG conjugates for the treatment of B cell lymphoma 5R01CA149254-03 $309,964 Timmerman, John UNIVERSITY OF CALIFORNIA AT LOS ANGELES
35
Antibody-interferon fusion proteins for treatment of B-cell malignancies 5R01CA162964-02 $319,550 MORRISON, SHERIE UNIVERSITY OF CALIFORNIA AT LOS ANGELES
36
Antibody-mediated Gene Therapy for the Treatment of Cancer 5K01CA138559-04 $142,677 Daniels, Tracy UNIVERSITY OF CALIFORNIA AT LOS ANGELES
37
Anticancer drug-induced BH3-only protein.Bak interactions 1R01CA166741-01 $332,564 KAUFMANN, SCOTT MAYO CLINIC
38
Approaches to discover and quantify apoptotic biomarkers for cancer treatment 5R01CA154802-02 $320,588 WELLS, JAMES UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
39
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-34S1 $75,000 Alberts, David UNIVERSITY OF ARIZONA
40
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-34S2 $143,846 Alberts, David UNIVERSITY OF ARIZONA
41
Arizona Cancer Center-Cancer Center Support Grant 5P30CA023074-34 $3,953,813 Alberts, David UNIVERSITY OF ARIZONA
42
ATBC Study ZIA CP010195-03031 $1,176,890 Albanes, Demetrius DCEG (NCI)
43
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIABC011413 $60,665 Kochenderfer, James CCR (NCI)
44
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research ZIGBC010856 $14,609,987 Custer, Mary CCR (NCI)
45
Basis for Lymphomagenesis in Akt2 Transgenic Mice 5R01CA077429-13 $410,451 TESTA, JOSEPH FOX CHASE CANCER CENTER
46
Bay Area Tumor Institute CCOP 2U10CA045461-23 $486,165 FEUSNER, JAMES BAY AREA TUMOR INSTITUTE
47
Baylor College of Medicine Cancer Center 3P30CA125123-06S1 $41,433 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
48
Baylor College of Medicine Cancer Center 3P30CA125123-06S2 $75,000 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
49
Baylor College of Medicine Cancer Center 5P30CA125123-06 $2,934,758 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
50
Bcl-2 function on the endoplasmic reticulum 5R01CA085804-13 $284,448 DISTELHORST, CLARK CASE WESTERN RESERVE UNIVERSITY
Relevant funding data is only available when one cancer type or one research topic is selected.
Showing 1 - 50 of 674 results
Go to top